Dr. Reddy’s Laboratories starts outsourcing manufacture of some of drugs to local partners

22 Nov 2019 Evaluate

Betting big on the Chinese market, Dr. Reddy’s Laboratories has started outsourcing manufacture of some of the drugs to local partners. The company which won the tender to market Olanzapine drug in China, is expected to launch it beginning next year.

The company is working towards filing and an eventual launch of over 70 products, across the chosen therapy areas, over the next few years. It has 8-10 products currently available in the market. All company’s products are marketed either through its Joint Venture, Kushnan Rotam Reddy Pharmaceuticals (KRRP) or through its partners in China. The products are manufactured either in the plant owned by KRRP in China, or partners in China, or in India by Dr. Reddy's.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

6263.70 46.55 (0.75%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.